Cutaneous Leishmaniasis: Physiopathology, Molecular Diagnostic, and Therapeutic Approaches by Abdelaali Balahbib, Asma Hmamouch, Aicha El Allam, Hikmat Douhri, Naoufal Dahaieh, Nasreddine El Omari, Jactty Chew, Long Chiau Ming, Abdelhakim Bouyahya

“… This in-depth study explores various aspects of cutaneous leishmaniasis, shedding light on the physiopathology of the infection, advances in molecular diagnostic techniques, and therapeutic approaches currently in development. …”
Get full text

Miltefosine Rescue Treatment for Visceral Leishmaniasis Relapse Patient by Anup Bastola, Mitesh Shrestha, Bimal Sharma Chalise, Abhdesh Kumar Mishra, Lina Devkota

“…We report the first case of miltefosine rescue treatment carried out for visceral leishmaniasis (VL) relapse patient. Despite undergoing treatment regimens of liposomal amphotericin B (LAMB) 5 mg/kg (standard: 10 mg/kg) daily for 3 days during the first episode followed by LAMB 5 mg/kg stat and paromomycin 15 mg/kg IM for 10 days against the second episode, the patient suffered from a third relapse and was eventually treated with miltefosine 50 mg BID directly observed treatment for 28 days. …”
Get full text

Development of Cutaneous Leishmaniasis after Leishmania Skin Test by Paulo R. Machado, Augusto M. Carvalho, Gustavo U. Machado, Marina L. Dantas, Sérgio Arruda

“…Thirty-year-old female with a previous history of a cutaneous ulcer suspicious of leishmaniasis 20 years ago presented with a new complaint of a depressed papular lesion 8×7 mm in the right lower extremity. …”
Get full text

A Case of Cutaneous Leishmaniasis Presenting to the Emergency Department by Gordon A, Malik AN

“…She was admitted on suspicion of leishmaniasis, and physicians of several specialties initiated a broad laboratory workup, collected wound cultures, prescribed antibiotics, and surgically repaired the lesion. …”
Get full text

Morphological Changes in the Bone Marrow of the Dogs with Visceral Leishmaniasis by Claudia Momo, Ana Paula Prudente Jacintho, Pamela Rodrigues Reina Moreira, Danísio Prado Munari, Gisele Fabrino Machado, Rosemeri de Oliveira Vasconcelos

“…Thirty-three dogs sacrificed at the Zoonosis Control Center of Araçatuba, a municipality endemic for visceral leishmaniasis (VL), were used. The animals were classified as asymptomatic, oligosymptomatic, and symptomatic groups. …”
Get full text

Localised Leishmaniasis of Oral Mucosa: Report of an Unusual Clinicopathological Entity by Deepak Passi, Sarang Sharma, Shubharanjan Dutta, Chandan Gupta

“…There are three main clinical forms of leishmaniasis: visceral leishmaniasis, cutaneous leishmaniasis, and mucocutaneous leishmaniasis. …”
Get full text

INTEGUMENTARY AND VISCERAL EPIDEMIOLOGICAL PROFILE OF LEISHMANIASIS IN MONTES CLAROS COUNTY by Fabricio Xavier Oliveira Pinheiro, Victoria Liery Ribeiro Alves, Yure Batista de Sousa, Mirela Lopes Figueiredo, Ana Augusta Maciel de Souza, Patrícia Fernandes Prado

“… The present study aims to describe the epidemiological profile American Integumentary Leishmaniasis (LTA)and Visceral Leishmaniasis (LV) in the Montes Claros/MG population between 2016 to 2020. …”
Get full text

Nanoemulsified Butenafine for Enhanced Performance against Experimental Cutaneous Leishmaniasis by Adriana Bezerra-Souza, Jéssica A. Jesus, Márcia D. Laurenti, Aikaterini Lalatsa, Dolores R. Serrano, Luiz Felipe D. Passero

“…This drug was active on parasites that cause cutaneous and visceral leishmaniasis. Based on the leishmanicidal activity of butenafine chloride and considering the absence of reports about the therapeutic potential of this drug in cutaneous leishmaniasis, the present work is aimed at analyzing the efficacy of butenafine formulated in two different topical delivery systems, the self-nanoemulsifying drug delivery systems (BUT-SNEDDS) and in a SNEDDS-based nanogel (BUT-SNEDDS gel) as well as in the free form in experimental cutaneous leishmaniasis. …”
Get full text

ATP-binding cassette transporters and drug resistance in cutaneous leishmaniasis by Marina B.R. de Santana, Giulia O. Miranda, Lucas P. Carvalho

“…In Brazil, pentavalent antimony (SbV), the main therapy used to treat all clinical forms of leishmaniasis, has become increasingly associated with treatment failure. …”
Get full text

Epidemiological analysis of Leishmaniasis prevalence in Pakistan during 2016-2023 by R. Uppal, U. Saeed, M. E. Khattak, A. A. Khan, M. R. Uppal, Z. Z. Piracha, M. N. Khan, D. Shaikh, U. Tariq, A. R. Mahmood, S. S. Ali, B. Muhammad, M. N. Tariq, S. S. Gilani, D. U. Ozsahin, B. Uzun, I. Ozsahin

Subjects: “…leishmaniasis…”
Get full text

Efficacy and Safety of Paromomycin for Visceral Leishmaniasis: A Systematic Review by Pashupati Pokharel, Rakesh Ghimire, Pratik Lamichhane

“…Paromomycin, an aminoglycoside drug, is frequently used for the treatment of visceral leishmaniasis. Despite limited therapies for visceral leishmaniasis and emerging drug resistance, a proper review on the action of paromomycin for kala-azar is lacking. …”
Get full text

Molecular diagnosis and epidemiological aspects of cutaneous Leishmaniasis in Aleppo: Current status by Lana Kourieh, Mohammad Y. Abajy, Mahasen Alkebajy, Silva Ishkhanian, Ream Nayal

Subjects: “…Cutaneous leishmaniasis…”
Get full text

Clinical and Immunological Analysis of Cutaneous Leishmaniasis before and after Different Treatments by José A. O'Daly, Humberto M. Spinetti, Joe Gleason, María B. Rodríguez

“…Patients (n=87) from a cutaneous leishmaniasis (CL) hyperendemic region receiving different treatments were followed up from January 1994 to August 2000. …”
Get full text

Efficacy and Safety of Miltefosine in Treatment of Post-Kala-Azar Dermal Leishmaniasis by Shyam Sundar, Anup Singh, Jaya Chakravarty, Madhukar Rai

“…Long regimens for the treatment of post-kala-azar dermal leishmaniasis (PKDL) result in noncompliance. A safe, effective, and acceptable regimen for the treatment of PKDL is still to be developed. …”
Get full text

Persian medicine’s novel approach: Cholagogue laxatives in the treatment of cutaneous leishmaniasis by Mehdi Shafiei-Bafti, Maryam Taghavi-Shirazi, Iraj Sharifi, Farzane Safa

Get full text

Dehydrothyrsiferol Against Cutaneous Leishmaniasis: Treatment Outcome in a Murine Model by Atteneri López-Arencibia, Carlos J. Bethencourt-Estrella, Desirée San Nicolás-Hernández, Rubén L. Rodríguez-Expósito, Angélica Domínguez-de-Barros, Lizbeth Salazar-Villatoro, Maritza Omaña-Molina, Francisco Cen-Pacheco, Ana R. Díaz-Marrero, José J. Fernández, Elizabeth Córdoba-Lanús, Jacob Lorenzo-Morales, José E. Piñero

Subjects: Get full text

A review of leishmaniasis: current knowledge and future directions of heterocyclic molecules by Tejaswini Masne, Dileep Kumar, Deepali Bansode

Subjects: Get full text

Challenges in the Therapy of Visceral Leishmaniasis in Brazil: A Public Health Perspective by Edson Carvalho de Melo, Carlos Magno Castelo Branco Fortaleza

Get full text

Visceral Leishmaniasis Clinical Management in Endemic Districts of India, Nepal, and Bangladesh by Megha Raj Banjara, Siddhivinayak Hirve, Niyamat Ali Siddiqui, Narendra Kumar, Sangeeta Kansal, M. Mamun Huda, Pradeep Das, Suman Rijal, Chitra Kumar Gurung, Paritosh Malaviya, Byron Arana, Axel Kroeger, Dinesh Mondal

Get full text

Microspatial Distributional Patterns of Vectors of Cutaneous Leishmaniasis in Pernambuco, Northeastern Brazil by Maria Rita Donalisio, A. Townsend Peterson, Pietra Lemos Costa, Fernando José da Silva, Hélio França Valença, Jeffrey J. Shaw, Sinval P. Brandão Filho

“…The purpose of this study is to analyze the spatial distribution and population trends through time of Lutzomyia species in a long-term focus of cutaneous leishmaniasis transmission in an Atlantic Forest area, northeastern Brazil. …”
Get full text